US Patent Issued to BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) on May 19 for "Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,421, issued on May 19, was assigned to BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) Co. LTD (Beijing).

"Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid" was invented by Chengyu Jiang (Beijing), Yuhao Qin (Beijing), Xiaoyun Li (Beijing) and Cong Zhang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an artificially synthesized single sphingosine lipid and use of delivering a nucleic acid thereof. More particularly, the invention provides Use or method for delivering a nucleic acid to a cell or a subject using a compound of Formula (I), a stereoisomer...